What are anti-neoplastic medications designed to do?

Anti-neoplastic medications are specifically designed to reduce or prevent the growth of cancer cells. These medications work by targeting rapidly dividing cells, which is characteristic of cancer. They can interfere with the cancer cells' ability to grow and divide, leading to a decrease in tumor size and the spread of cancer.

In the context of cancer treatment, these drugs can work through various mechanisms, such as damaging the DNA of cancer cells, inhibiting enzymes necessary for their replication, or interfering with the formation of the cellular structures required for cell division. Ultimately, the primary therapeutic goal of anti-neoplastic medications is to control the disease, improve survival rates, and enhance the quality of life for patients with cancer.

The other answer choices do not align with the purpose of anti-neoplastic medications. For instance, promoting the growth of cancer cells would directly contradict their intended use, while enhancing mitosis in healthy cells or solely stimulating immune responses to tumors does not reflect the primary action of these drugs. Understanding the role of anti-neoplastic medications is crucial for anyone involved in the care of patients undergoing cancer treatment.